New microneedle patch detects silent heart injury after surger

Researchers at McMaster University have developed a wearable device that could help detect silent heart injury in the days after surgery, offering a new way to monitor patients after they leave the hospital.

The technology continuously measures cardiac troponin, a protein released when the heart is injured, using a patch equipped with tiny, painless microneedles that sample fluid beneath the skin. The findings were published today in the journal Science Advances.

The work addresses a significant challenge in post-surgical care. About 300 million people undergo non-cardiac surgery each year, and increasing numbers of people are discharged home the same day.

But the days immediately following surgery remain a period of elevated risk, with about 20 per cent of higher risk patients experiencing myocardial injury after non-cardiac surgery, or MINS. Most of these cases occur without obvious symptoms.

About 90 per cent of these cases are silent. The only way to diagnose many of them is through a blood test, which is difficult when patients are already home. We wanted to develop a way to continuously monitor for heart injuries without requiring repeated blood draws."

Leyla Soleymani, professor of Engineering Physics and lead of engineering innovation, NexusHealth

The wearable device uses microscopic polymer needles that penetrate just beneath the skin, without reaching nerves or blood vessels. The microneedles collect interstitial fluid, the liquid that surrounds cells, and deliver it to a biosensor that's able to continuously track cardiac troponin levels over several days.

While continuous monitoring technology already exists for biomarkers such as glucose, proteins are much harder to track continuously. Cardiac troponin is present at very low concentrations in bloodstream and becomes even more diluted in the fluid beneath the skin.

"That's what makes this such an important advance. We're monitoring a protein that's present at very low levels and doing it continuously in living tissue," Soleymani says.

This device builds on previous work by Soleymani and the team in biosensing and aptamer engineering. Aptamers are short strands of DNA or RNA engineered to recognize specific biological targets.

Earlier versions of the technology monitored smaller molecules such as lactate. To detect proteins, researchers combined antibodies, which recognize proteins, and aptamers, which generate a measurable signal. The resulting sensor can continuously track biomarker levels over several days.

"A lot of different pieces had to come together for this work. We had to develop new sensing strategies, create a way to continuously refresh the sensor and integrate everything into a device patients could comfortably wear," says Soleymani. 

The project brought together expertise from multiple institutions and disciplines. Researchers at the University of Waterloo developed the microneedle technology that made continuous sampling possible.

The work builds on McMaster's internationally recognized leadership in myocardial injury after non-cardiac surgery, helping lay the foundation for technologies designed to identify patients at risk and enable earlier intervention.

The research team has received funding from the Canadian Institutes of Health Research (CIHR) to advance the technology through additional testing.

Researchers are also pursuing commercialization through Aptec Health, a startup founded to help bring the technology to patients.

While the immediate focus is post-surgical monitoring, the researchers see much broader possibilities across medicine. Many of the most important health changes happen between clinic visits, and technologies like this could provide a more continuous picture of what's happening in between appointments.

"The future of medicine is personalized, and personalized medicine needs data," says Soleymani.

For her, the project reflects the type of research that motivates her most: tackling difficult scientific challenges that could make a meaningful difference in people's lives.

"I like working on hard problems, and I like working on meaningful problems. This one has both."

Source:
Journal reference:

Zheng, H., et al. (2026). Beyond metabolites: A wearable biointerface integrating antibody and aptamer probes for the real-time tracking of proteins in vivo. Science Advances. DOI: 10.1126/sciadv.aej0899. https://www.science.org/doi/10.1126/sciadv.aej0899

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Brain-heart communication offers clues to survival after cerebral anoxia